127 related articles for article (PubMed ID: 6159323)
1. [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].
Mishler JM
Infusionsther Klin Ernahr; 1980 Apr; 7(2):96-102. PubMed ID: 6159323
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of high molecular weight hydroxyethyl starch in dogs.
Yacobi A; Gibson TP; McEntegart CM; Hulse JD
Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):199-204. PubMed ID: 6179136
[TBL] [Abstract][Full Text] [Related]
3. [Mathematical decription of the human intravascular elimination of HAS after repeated infusions].
Mishler JM; Beez M
Infusionsther Klin Ernahr; 1979 Apr; 6(2):119-22. PubMed ID: 85606
[TBL] [Abstract][Full Text] [Related]
4. [Blood volume replacement and hemodilution with hydroxyethyl starch].
Messmer K; Jesch F
Infusionsther Klin Ernahr; 1978 Jun; 5(3):169-77. PubMed ID: 78893
[TBL] [Abstract][Full Text] [Related]
5. [The in vivo molecular weight and renal threshold of hydroxyethyl starch in the example of molar substituted HES70/0/5].
Förster H; Lehmann G; Asskali F
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jan; 36(1):31-7. PubMed ID: 11227306
[TBL] [Abstract][Full Text] [Related]
6. [The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers].
Asskali F; Förster H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Sep; 34(9):537-41. PubMed ID: 10542895
[TBL] [Abstract][Full Text] [Related]
7. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
[TBL] [Abstract][Full Text] [Related]
8. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
Gandhi SD; Weiskopf RB; Jungheinrich C; Koorn R; Miller D; Shangraw RE; Prough DS; Baus D; Bepperling F; Warltier DC
Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
[TBL] [Abstract][Full Text] [Related]
10. Resuscitation from hemorrhagic shock with hydroxyethyl starch and coagulation changes.
Cabrales P; Tsai AG; Intaglietta M
Shock; 2007 Oct; 28(4):461-7. PubMed ID: 17558350
[TBL] [Abstract][Full Text] [Related]
11. Effect of hydroxyethyl starch solution in normal horses and horses with colic or acute colitis.
Schusser GF; Rieckhoff K; Ungemach FR; Huskamp NH; Scheidemann W
J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):592-8. PubMed ID: 18045345
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of colloidal volume replacement solution 6% HES 40/0.5].
Halmágyi M
Anaesthesist; 1984 Feb; 33(2):73-81. PubMed ID: 6201084
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyethyl starch: the effect of molecular weight and degree of substitution on intravascular retention in vivo.
Hitosugi T; Saito T; Suzuki S; Kubota I; Shoda E; Shimizu T; Oi Y
Anesth Analg; 2007 Sep; 105(3):724-8. PubMed ID: 17717230
[TBL] [Abstract][Full Text] [Related]
14. Studies on hydroxyethyl starch. Part II: Changes of the molecular weight distribution for hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3 and 200/0.1 after infusion in serum and urine of volunteers.
Ferber HP; Nitsch E; Förster H
Arzneimittelforschung; 1985; 35(3):615-22. PubMed ID: 2581591
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
Koscielny J; Jung F; Mrowietz C; Pindur G; Förster H; Schimetta W; Kiesewetter H; Wenzel E
Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833
[TBL] [Abstract][Full Text] [Related]
16. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
[TBL] [Abstract][Full Text] [Related]
17. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
Kröll W; Pölz W; Colombo T; Steindorfer P
Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
[TBL] [Abstract][Full Text] [Related]
18. Studies on hydroxyethyl starch. Part I: Molecular characterization by size exclusion chromatography coupled with low-angle laser light scattering.
Lederer K; Huber C; Dunky M; Fink JK; Ferber HP; Nitsch E
Arzneimittelforschung; 1985; 35(3):610-4. PubMed ID: 2581590
[TBL] [Abstract][Full Text] [Related]
19. [[Comparison of hydroxyethyl starch solutions derived from potato and corn starch] ].
Rauch S; Sefrin P
Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Dec; 35(12):750-5. PubMed ID: 11194516
[TBL] [Abstract][Full Text] [Related]
20. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
